مشروع البحث:
Seroprevalence and Associated Risk Factors of Hepatitis E Infection among Healthy Blood Donors

dc.contributor.advisorGoma Mohamed Huwiage
dc.date.accessioned2024-11-25T10:03:00Z
dc.date.available2024-11-25T10:03:00Z
dc.descriptionThis is the first study to investigate the seroprevalence of HEV infection and associated risk factors among Libyan Healthy blood donors. The present study revealed that the overall seroprevalence of HEV infection among the healthy blood donors of Tripoli, Libya was low at 5.24%. Furthermore, the seroprevalence of anti-HEV IgG was 4.49%, while the seroprevalence of both anti-HEV antibodies (IgM and IgG) was 0.74%. As a result, Libya might be considered an endemic nation for HEV.
dc.description.abstractBackground: Blood transfusion may lead to a variety of complications such as transfusion- transmitted infections (TTIs). Transfusion-transmitted emerging infectious diseases represent one of the threats to blood safety. Hepatitis E (HE) is a transfusion- transmitted emerging viral disease caused by the Hepatitis E virus (HEV). There are currently no national seroprevalence reports for Libyan blood donors. This study therefore aimed to evaluate HEV risk to blood safety, by assessing the prevalence of anti-HEV IgG and anti-HEV IgM among Libyan healthy blood donors. Material and methods: A total of 267 serum samples were collected from blood donors. Using a questionnaire form, the sociodemographic information and risk factors for HEV infection of all blood donors were gathered. The sera of the blood donors were screened for anti-HEV IgM and anti-HEV IgG using ELISA kits (DIA. PRO Srl, Milan, Italy). Results obtained were analyzed using Statistical Package for Social Sciences (SPSS) version 26.0 statistical software.
dc.identifier2322
dc.identifier.urihttps://dspace.academy.edu.ly/handle/123456789/313
dc.subjectSeroprevalence and Associated Risk Factors of Hepatitis E Infection among Healthy Blood Donors
dc.titleSeroprevalence and Associated Risk Factors of Hepatitis E Infection among Healthy Blood Donors
dspace.entity.typeProject
project.endDate2023
project.funder.nameعلوم الاساسية
project.investigatorAli Mustafa Albasheeri
project.startDate2022
الملفات
الحزمة الأصلية
يظهر اﻵن 1 - 1 من 1
لا توجد صورة مصغرة متاحة
اﻻسم:
Ser HEV3011- -.docx
الحجم:
2.37 MB
التنسيق:
Microsoft Word XML
حزمة الترخيص
يظهر اﻵن 1 - 1 من 1
لا توجد صورة مصغرة متاحة
اﻻسم:
license.txt
الحجم:
1.71 KB
التنسيق:
Item-specific license agreed to upon submission
الوصف: